Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    23199894 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Safety and Pregnancy Outcomes in Thrombocythemia Patients Exposed to XAGRID® (Anagrelide Hydrochloride) Compared to Other Treatments
Condition: Thrombocythemia, Essential
Intervention:

Study has passed its completion date and status has not been verified in more than two years.